Association of Genetic Polymorphisms in TNF and MIF Gene with the Risk of Primary Dysmenorrhea

@article{Doru2016AssociationOG,
  title={Association of Genetic Polymorphisms in TNF and MIF Gene with the Risk of Primary Dysmenorrhea},
  author={Hatice Yılmaz Doğru and Asker Zeki Ozsoy and Nevin Karakuş and Ilhan Bahri Delibas and Çigdem Kunt Isguder and Serbulent Yigit},
  journal={Biochemical Genetics},
  year={2016},
  volume={54},
  pages={457-466}
}
Primary dysmenorrhea, which affects 90 % of adolescent girls and more than 50 % of menstruating women worldwide, is characterized by recurrent pain during menses in the absence of a detectable organic disease. The aim of this study is to assess the association between MIF −173 and TNF −308 genetic polymorphisms and the clinical features of primary dysmenorrhea. The study population comprised 154 unrelated female patients with clinical diagnosis of dysmenorrhea, and a total of 144 control… 
Dysmenorrhea and Associated Factors among Polish Women: A Cross-Sectional Study
TLDR
The study points to the fact that the problem of dysmenorrhea affects many Polish women and suggests that further assessment of factors contributing for dys menorrhea among women is necessary.
Primary Dysmenorrhea: pathophysiology
TLDR
The pathophysiology of primary dysmenorrhea and the implications of other chemical substances was analyzed and publications from January 1980 to February 2021 were reviewed.
An Evaluation of the Effectiveness of Ibuprofen and Manual Therapy in Young Women with Dysmenorrhea—A Pilot Study †
TLDR
Manual therapy may reduce menstrual pain in women with dysmenorrhea, however, the results need to be confirmed in studies conducted on a larger group of patients with dys menorrhea.
Inflammatory Markers in Dysmenorrhea and Therapeutic Options
TLDR
The present work contains a review of the latest research concerning factors involved in dysmenorrhea, as well as therapeutic options, using online databases, PubMed, and clinitrials.gov.
The Role of Tumor Necrosis Factor α in the Biology of Uterine Fibroids and the Related Symptoms
TLDR
Current data about the role of tumor necrosis factor α in the biology of UFs and the related symptoms are presented and the presence of an “inflammation-like” state in women with UFs where TNF-α is a potent inflammation inducer is suggested.
Experimental evaluation of central pain processes in young women with primary dysmenorrhea.
TLDR
Enhanced pain sensitivity in young women with PD as measured by heat pain tolerance and Average Pain50 (P50) is indicated, compared with healthy controls, although no evidence of enhanced excitatory or deficient inhibitory mechanisms were observed.
Acupuncture for Primary Dysmenorrhea: A Potential Mechanism from an Anti-Inflammatory Perspective
TLDR
The role of inflammation in PD pathophysiology is portrayed, evidence from clinical and animal studies on acupuncture for inflammation-induced visceral pain is provided, and on acupuncture-related therapies for dysmenorrhea with regard to their anti-inflammatory characteristics are reflected.
The effect of ulipristal acetate on tumor necrosis factor alpha, insulin-like growth factor 1, and plasminogen activator inhibitor-1 serum levels in patients with symptomatic uterine fibroids
TLDR
A retrospective cohort study to evaluate and compare tumor necrosis factor alpha (TNF-α), insulin-like growth factor 1 (IGF-1), plasminogen activator inhibitor-1 (PAI-1) serum concentrations in patients with UFs without prior hormonal treatment found no significant differences.

References

SHOWING 1-10 OF 27 REFERENCES
Serum macrophage migration inhibitory factor (MIF) in the intercritical phase of hereditary periodic fevers and its relationship with the MIF‐173G/C polymorphism
TLDR
The MIF‐173*C allele was found more frequently in patients with HPF than in controls and MIF serum concentrations were considerably elevated in attack‐free phases, suggesting a persistent state of subclinical cytokine activation with MIF involvement in the autoinflammatory cascade.
A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease
TLDR
Functional promoter polymorphisms in the MIF gene influence plasma MIF levels in AOSd and may contribute to disease susceptibility or clinical presentation of AOSD.
A novel 5′‐flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic‐onset juvenile idiopathic arthritis
TLDR
This is the first report of a SNP in the MIF gene associated with systemic-onset JIA, identified in the 5′-flanking region of the gene, using polymerase chain reaction–restriction fragment length analysis.
Altered Cytokine Gene Expression in Peripheral Blood Monocytes across the Menstrual Cycle in Primary Dysmenorrhea: A Case-Control Study
TLDR
This first study of cytokine gene expression profiles in PBMCs from young primary dysmenorrheic women demonstrates a shift in the balance between expression patterns of pro-inflammatory cytokines and TGF-β superfamily members across the whole menstrual cycle, underlying the peripheral immunologic features of primary Dysmenorrhea.
Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke
TLDR
In vitro evaluation of potential interaction between variants of the TNF-α gene (−308G/A, -857C/T, and -1031T/C) demonstrated that these three polymorphisms could interact together to determine the overall activity of theTNF- α gene.
Impact of the ‐308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease
TLDR
The majority of the data support a direct role for the T NF2 ‐308 allele in the elevated TNF levels observed in TNF2 homozygotes and HLA‐A1, B8, DR3 individuals.
Leukotrienes in gynaecology: the hypothetical value of anti-leukotriene therapy in dysmenorrhoea and endometriosis.
TLDR
The case for the potential use of leukotriene receptor antagonists in the management of primary dysmenorrhoea (especially in patients who are not responding to the traditional treatment using PG synthetase inhibitors) and possibly also in cases of endometriosis is presented.
...
...